This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Akiko Shoyama: Innovator in Cancer Treatment
Introduction
Akiko Shoyama is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicine, particularly in cancer treatment. Her innovative work has led to the development of a unique combination of therapeutic agents that show promise in combating tumors.
Latest Patents
Akiko Shoyama holds a patent for a combination comprising an EP4 antagonist and an immune checkpoint inhibitor. This medicament includes a compound represented by a specific formula, along with an immune checkpoint inhibitor, such as an anti-PD-1 antibody. This combination exhibits a strong anti-tumor effect, making it a valuable option for cancer treatment.
Career Highlights
Shoyama is currently employed at Ono Pharmaceutical Co., Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in pushing the boundaries of cancer therapeutics, and she is recognized for her innovative approach to treatment.
Collaborations
Throughout her career, Akiko has collaborated with notable colleagues, including Takao Yoshida and Hirotsugu Takano. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Akiko Shoyama's contributions to cancer treatment through her innovative patent highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile